<?xml version="1.0" encoding="utf-8"?><!DOCTYPE article PUBLIC "-//ES//DTD journal article DTD version 5.0.2//EN//XML" "art502.dtd" [<!ENTITY gr1 SYSTEM "gr1" NDATA IMAGE><!ENTITY gr2a SYSTEM "gr2a" NDATA IMAGE><!ENTITY gr2bc SYSTEM "gr2bc" NDATA IMAGE><!ENTITY gr3 SYSTEM "gr3" NDATA IMAGE><!ENTITY gr4 SYSTEM "gr4" NDATA IMAGE>]><article docsubtype="sco" xml:lang="en"><ce:floats xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:figure id="fig1"><ce:label>Fig. 1</ce:label><ce:caption><ce:simple-para>Surface immunofluorescence of the enlargeosome marker, d/A, indicative of recent exocytosis. Panels A and B show that resting PC12-27 cells, pretreated (B) or not (A) with GNS (5<ce:hsp sp="0.25"/>min, 100<ce:hsp sp="0.25"/>μM) exhibit very low immunofluorescence, which in contrast is increased in the cells stimulated with ionomycin (3<ce:hsp sp="0.25"/>μM, 3<ce:hsp sp="0.25"/>min) (panel C), especially when pretreated with GNS (D). The bar in A, valid also for the other panels, is 5<ce:hsp sp="0.25"/>μm. Data in E were from at least 20 randomly selected cell/groups. Differences of ionomycin and GNS<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>ionomycin versus control, and ionomycin versus GNS<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>ionomycin are highly significant (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.01).</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Fig. 2</ce:label><ce:caption><ce:simple-para>Cell surface increases induced by ionomycin in cells pretreated or not with GNS, revealed by patch-clamping and FM1-43. Panel A shows typical capacitance patch clamp traces of PC12-27 cells stimulated by uncaging NP-EGTA (arrow) after no pre-treatment (control) or pre-treatment with GNS; panels B and C the analyzed patch-clamp data (7–8 cells/group) showing the rate of the capacitance increase (B) and the extent of the responses (C). Panels D and E show the FM1-43 responses analogous to the patch-clamp responses of A and B, where pre-treatment was with GNS 100<ce:hsp sp="0.25"/>μM, 5<ce:hsp sp="0.25"/>min, and the exocytosis was triggered by the administration of ionomycin 3<ce:hsp sp="0.25"/>μM (13 experiments). Panels F and G show the concentration-dependence of the responses induced by one of the two drugs in the presence of a fixed concentration of the other: GNS at various concentrations followed by ionomycin 3<ce:hsp sp="0.25"/>μM; and ionomycin at various concentrations preceded by GNS 100<ce:hsp sp="0.25"/>μM (three experiments). Panel H shows the reinforcement induced by GNS (100<ce:hsp sp="0.25"/>μM) pre-treatment of 5, 15 and 30<ce:hsp sp="0.25"/>min. In all panels control<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>ionomycin alone, 3<ce:hsp sp="0.25"/>μM (21 experiments). Differences with respect to controls in panels B, C, and E–H are all statistically significant (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.05 or lower) except for the 0.1<ce:hsp sp="0.25"/>μM ionomycin and the 30<ce:hsp sp="0.25"/>min value of panels G and H.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Fig. 3</ce:label><ce:caption><ce:simple-para>Reinforcement of the ionomycin-induced exocytosis by pre-treatment with GNS or/and latrunculinA. Pre-treatment with latrunculinA (5<ce:hsp sp="0.25"/>μM) was for 15<ce:hsp sp="0.25"/>min; that with GNS (100<ce:hsp sp="0.25"/>μM) for 5<ce:hsp sp="0.25"/>min. In the combined treatment the cells received the first at −15 and the second at −5<ce:hsp sp="0.25"/>min. Control<ce:hsp sp="0.25"/>=<ce:hsp sp="0.25"/>ionomycin alone, 3<ce:hsp sp="0.25"/>μM. Results from three experiments. Differences with respect to control (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.01) and GNS versus latrunculinA (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.05) are significant; GNS<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>latrunculinA versus GNS is not (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&gt;<ce:hsp sp="0.25"/>0.05).</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:table frame="topbot" id="tbl1" rowsep="0" colsep="0"><ce:label>Table 1</ce:label><ce:caption><ce:simple-para>Enlargeosome exocytosis: lack of reinforcement of the ionomycin-induced response by drugs other than GNS, affecting tyrosine phosphorylation and/or inducing additional (non-TK-dependent) effects of GNS</ce:simple-para></ce:caption><tgroup cols="6"><colspec colname="col1" align="left"/><colspec colname="col2" align="left"/><colspec colname="col3" align="left"/><colspec colname="col4" align="left"/><colspec colname="col5" align="char" char="[plusmn]"/><colspec colname="col6" align="char" char="."/><thead><row rowsep="1" valign="top"><entry/><entry>Drug targets</entry><entry>Concentrations used (μM)</entry><entry>Preincubation (min)</entry><entry>Rate of Fluo Change (a.u.)/sec</entry><entry>Fold changes versus ionomycin</entry></row></thead><tbody><row valign="top"><entry>GNS</entry><entry>TKs and non-TKs</entry><entry>100<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>5</entry><entry align="char" char="[plusmn]">3.5<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.46</entry><entry align="char" char=".">2.5</entry></row><row valign="top"><entry>LavendustinA</entry><entry>TKs</entry><entry>10<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>5</entry><entry align="char" char="[plusmn]">1.33<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.3</entry><entry align="char" char=".">0.3</entry></row><row valign="top"><entry>HerbimycinA</entry><entry>Src family TKs</entry><entry>1</entry><entry>15</entry><entry align="char" char="[plusmn]">1.15<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.17</entry><entry align="char" char=".">0.15</entry></row><row valign="top"><entry>PP2</entry><entry>Src TKs</entry><entry>10</entry><entry>15</entry><entry align="char" char="[plusmn]">1.3<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.7</entry><entry align="char" char=".">0.3</entry></row><row valign="top"><entry>Piceatannol</entry><entry>Syk, Lck TKs</entry><entry>10</entry><entry>15</entry><entry align="char" char="[plusmn]">0.75<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.05</entry><entry align="char" char=".">−0.25</entry></row><row valign="top"><entry>Orthovanadate</entry><entry>Tyrosine phosphatases</entry><entry>10<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>15</entry><entry align="char" char="[plusmn]">0.63<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.07</entry><entry align="char" char=".">−0.37</entry></row><row valign="top"><entry>GNS<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>orthovanadate</entry><entry>TKs and non-TKs<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>tyrosine phosphatases</entry><entry>100<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>10</entry><entry>5<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>15</entry><entry align="char" char="[plusmn]">3.25<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.25</entry><entry align="char" char=".">2.25</entry></row><row valign="top"><entry>Daidzein</entry><entry>Non-TKs</entry><entry>100<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>5</entry><entry align="char" char="[plusmn]">0.9<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.15</entry><entry align="char" char=".">−0.1</entry></row><row valign="top"><entry>UO126</entry><entry>MEK1, MEK2</entry><entry>10<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>60</entry><entry align="char" char="[plusmn]">0.95<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.15</entry><entry align="char" char=".">−0.05</entry></row><row valign="top"><entry>LY294002</entry><entry>PI<ce:inf>3</ce:inf> kinase</entry><entry>25</entry><entry>30</entry><entry align="char" char="[plusmn]">1.1<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.1</entry><entry align="char" char=".">0.1</entry></row><row valign="top"><entry>Forskolin</entry><entry>Adenylate cyclase</entry><entry>1<ce:cross-ref refid="tblfn1"><ce:sup>a</ce:sup></ce:cross-ref></entry><entry>10</entry><entry align="char" char="[plusmn]">1.5<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.5</entry><entry align="char" char=".">0.5</entry></row><row valign="top"><entry>IBMX</entry><entry>Phosphodiesterase</entry><entry>500</entry><entry>5</entry><entry align="char" char="[plusmn]">0.95<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.05</entry><entry align="char" char=".">−0.05</entry></row><row valign="top"><entry>H89</entry><entry>Protein kinase A</entry><entry>10</entry><entry>30</entry><entry align="char" char="[plusmn]">0.89<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.1</entry><entry align="char" char=".">−0.11</entry></row><row valign="top"><entry>Genistin</entry><entry>Inactive GNS analogue</entry><entry>100</entry><entry>5</entry><entry align="char" char="[plusmn]">0.75<ce:hsp sp="0.25"/>±<ce:hsp sp="0.25"/>0.05</entry><entry align="char" char=".">−0.25</entry></row></tbody></tgroup><ce:legend><ce:simple-para>Results shown are averages of at least three experiments carried out by FM1-43 fluorometry of cell suspensions.</ce:simple-para></ce:legend><ce:table-footnote id="tblfn1"><ce:label>a</ce:label><ce:note-para>Indicates drugs used also at other concentrations (μM), with consistent results: GNS: 10, 30, 60, 300; lavendustinA: 10, 100; orthovanadate: 10, 100; daidzein: 100, 300; UO126: 1, 10; forskolin: 1, 10. Except for GNS (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&lt;<ce:hsp sp="0.25"/>0.01), the differences in rate of fluorescence change with respect to controls (ionomycin alone) were non-significant (<ce:italic>P</ce:italic><ce:hsp sp="0.25"/>&gt;<ce:hsp sp="0.25"/>0.05).</ce:note-para></ce:table-footnote></ce:table></ce:floats><head><ce:title xmlns:ce="http://www.elsevier.com/xml/common/dtd">The Ca<ce:sup>2+</ce:sup>-dependent exocytosis of enlargeosomes is greatly reinforced by genistein via a non-tyrosine kinase-dependent mechanism</ce:title><ce:presented xmlns:ce="http://www.elsevier.com/xml/common/dtd">Edited by Lukas Huber</ce:presented><ce:author-group xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:author><ce:given-name>Ilaria</ce:given-name><ce:surname>Prada</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Emanuele</ce:given-name><ce:surname>Cocucci</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Gabriella</ce:given-name><ce:surname>Racchetti</ce:surname><ce:cross-ref refid="aff2"><ce:sup>b</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Jacopo</ce:given-name><ce:surname>Meldolesi</ce:surname><ce:cross-ref refid="aff1"><ce:sup>a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2"><ce:sup>b</ce:sup></ce:cross-ref><ce:cross-ref refid="aff3"><ce:sup>c</ce:sup></ce:cross-ref><ce:cross-ref refid="aff4"><ce:sup>d</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1"><ce:sup>⁎</ce:sup></ce:cross-ref><ce:e-address type="email">meldolesi.jacopo@hsr.it</ce:e-address></ce:author><ce:affiliation id="aff1"><ce:label>a</ce:label><ce:textfn>Vita-Salute San Raffaele University, Center of Excellence in Cell Development, via Olgettina 58, 20132 Milan, Italy</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>b</ce:label><ce:textfn>Scientific Institute San Raffaele, via Olgettina 58, 20132 Milan, Italy</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>c</ce:label><ce:textfn>Istituto Nazionale di Neuroscienze, via Olgettina 58, 20132 Milan, Italy</ce:textfn></ce:affiliation><ce:affiliation id="aff4"><ce:label>d</ce:label><ce:textfn>IIT Network, Research Unit of Molecular Neuroscience, via Olgettina 58, 20132 Milan, Italy</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>⁎</ce:label><ce:text>Corresponding author. Address: Vita-Salute San Raffaele University, DIBIT, via Olgettina 58, 20132 Milan, Italy. Fax: +39 02 26434813.</ce:text></ce:correspondence></ce:author-group><ce:abstract class="author" xml:lang="en" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Studies carried out by immunofluorescence, patch-clamping and FM dye fluorescence consistently showed that the Ca<ce:sup>2+</ce:sup>-induced exocytosis of enlargeosomes, specific vesicles expressed by many cell types, is strongly reinforced by pre-treatment of the cells with genistein, a wide spectrum blocker of tyrosine kinases, which also induces many additional effects. Various other blockers of tyrosine kinases, however, were ineffective, and the same occurred with drugs mimicking most of the rapid, non-tyrosine kinase-dependent effects of genistein. The reinforcement of enlargeosome-regulated exocytosis, therefore, is a new effect of genistein and a peculiar property of the enlargeosome exocytosis, not shared by analogous processes.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords class="abr" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Abbreviations</ce:section-title><ce:keyword><ce:text>d/A</ce:text><ce:keyword><ce:text>desmoyokin/Ahnak</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>GNS</ce:text><ce:keyword><ce:text>genistein</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>NP-EGTA</ce:text><ce:keyword><ce:text><ce:italic>o</ce:italic>-nitrophenyl EGTA</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>TK</ce:text><ce:keyword><ce:text>tyrosine kinase</ce:text></ce:keyword></ce:keyword><ce:keyword><ce:text>TRITC</ce:text><ce:keyword><ce:text>tetramethylrhodamine isothiocyanate</ce:text></ce:keyword></ce:keyword></ce:keywords><ce:keywords class="keyword" xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>Desmoyokin/Ahnak</ce:text></ce:keyword><ce:keyword><ce:text>Patch-clamping</ce:text></ce:keyword><ce:keyword><ce:text>FM dye</ce:text></ce:keyword><ce:keyword><ce:text>Immunocytochemistry</ce:text></ce:keyword></ce:keywords></head><body><ce:sections xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section><ce:label>1</ce:label><ce:section-title>Introduction</ce:section-title><ce:para>Regulated exocytosis, the process by which specific organelles, both secretory and non-secretory, fuse with the plasma membrane in response to stimulation, has been investigated in many cell types. In addition to Ca<ce:sup>2+</ce:sup>, which in most cells is the main trigger, other messengers (cAMP, diacylglicerol) were found to play a stimulatory role. The effects attributed to tyrosine kinases (TK) were more variable. Reinforcement of exocytic responses induced by Ca<ce:sup>2+</ce:sup> was reported in various cell systems <ce:cross-refs refid="bib1 bib2 bib3 bib4">[1–4]</ce:cross-refs>. In others, however, TKs induced no change <ce:cross-refs refid="bib5 bib6">[5,6]</ce:cross-refs> or inhibited the Ca<ce:sup>2+</ce:sup>-induced exocytoses <ce:cross-refs refid="bib7 bib8">[7,8]</ce:cross-refs>. Finally, at brain glutamatergic synapses one laboratory reported a TK-dependent reinforcement while another reported an inhibition <ce:cross-refs refid="bib9 bib10">[9,10]</ce:cross-refs>.</ce:para><ce:para>Many of the above conclusions were not based on direct results but extrapolated from the effects of TK blockers, most often the large spectrum isoflavone genistein (GNS), used alone or in parallel with other drugs <ce:cross-refs refid="bib1 bib2 bib4 bib5 bib6 bib8 bib9">[1,2,4–6,8,9]</ce:cross-refs>. This approach, however, is open to some question. In fact, the various TK blockers used can have different target specificity; moreover, their action depends not only on the block of TKs but also on TK-independent effects, referred to here as additional effects. The additional effects of GNS are numerous, and some of them, such as the block of Ca<ce:sup>2+</ce:sup> <ce:cross-refs refid="bib11 bib12">[11,12]</ce:cross-refs>; the increase of cAMP <ce:cross-refs refid="bib13 bib14">[13,14]</ce:cross-refs>; the block of IP<ce:inf>3</ce:inf> kinase <ce:cross-ref refid="bib15">[15]</ce:cross-ref>; the disassembly of the actin cytoskeleton <ce:cross-ref refid="bib16">[16]</ce:cross-ref>, occur within min from drug application and therefore can affect exocytosis even in short-term experiments.</ce:para><ce:para>Here we report about reinforcement by GNS of the regulated exocytosis of enlargeosomes. The latter are specific vesicles, discovered a few years ago in numerous cell types and abundant in a clone of PC12 cells defective of classical neurosecretion, the PC12-27 clone <ce:cross-refs refid="bib17 bib18 bib19">[17–19]</ce:cross-refs>. Upon [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> increase, enlargeosomes are rapidly discharged by exocytosis (time constant ∼1<ce:hsp sp="0.25"/>s <ce:cross-ref refid="bib20">[20]</ce:cross-ref>), inducing a considerable enlargement of the cell surface <ce:cross-refs refid="bib18 bib19 bib20 bib21">[18–21]</ce:cross-refs>. During the characterization of the latter process we noticed its strong reinforcement by GNS, occurring however neither via TK inhibition, nor via the numerous additional effects of the drug known so far.</ce:para></ce:section><ce:section role="materials-methods"><ce:label>2</ce:label><ce:section-title>Materials and methods</ce:section-title><ce:para>PC12-27 cells were grown as specified in <ce:cross-ref refid="bib17">[17]</ce:cross-ref>. The monoclonal anti-desmoyokin/Ahnak (d/A) antibody was generated in our laboratory. tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-mouse IgGs were bought from Southern Biotech, Birmingham AL, USA; FM1-43 from Molecular Probes, Eugene, OR, USA; ionomycin, lavendustinA, herbimycinA, PP2, piceatannol, genistin and forskolin from Calbiochem, Schwalbach, Germany; GNS, orthovanadate, daidzein, LY294002, IBMX and H89 from Sigma, Milan Italy; UO126 from Promega, Madison, WS, USA; latrunculinA from Invitrogen, Carlsbad, CA, USA.</ce:para><ce:section><ce:label>2.1</ce:label><ce:section-title>Confocal immunofluorescence</ce:section-title><ce:para>For surface immunofluorescence of d/A, PC12-27 cells, grown on poly-<ce:small-caps>l</ce:small-caps>-lysine-coated coverslips and exposed or not to drug pre-treatment, were challenged or not with ionomycin (3<ce:hsp sp="0.25"/>μM, 3<ce:hsp sp="0.25"/>min) while bathed at 37<ce:hsp sp="0.25"/>°C in Krebs–Ringer–HEPES medium, then transferred on ice and fixed with 4% formaldehyde in PBS, pH 7.4. After quenching with 0.1<ce:hsp sp="0.25"/>M glycine and washing in PBS containing 0.5% BSA and 5% goat serum (no permeabilization), they were immunolabeled with the anti-d/A monoclonal and then with the TRITC-labeled secondary antibody in PBS/BSA. Cells were studied in a Bio-Rad MRC 1024 confocal microscope. Quantitation of the data was as in <ce:cross-ref refid="bib18">[18]</ce:cross-ref>.</ce:para></ce:section><ce:section><ce:label>2.2</ce:label><ce:section-title>Patch-clamping</ce:section-title><ce:para>Whole-cell patched PC12-27 cells, loaded with <ce:italic>o</ce:italic>-nitrophenyl EGTA (NP-EGTA) with or without GNS (10<ce:hsp sp="0.25"/>μM) in the pipette and recorded at 37<ce:hsp sp="0.25"/>°C in continuous perfusion, were illuminated with a monochromatic light (380<ce:hsp sp="0.25"/>nm) short-pass filtered at 410<ce:hsp sp="0.25"/>nm and reflected in the perfusion chamber by a dichroic mirror centered at 400<ce:hsp sp="0.25"/>nm, sufficient to release the caged Ca<ce:sup>2+</ce:sup> continuously <ce:cross-ref refid="bib18">[18]</ce:cross-ref>. Compensated membrane capacitance (<ce:italic>C</ce:italic><ce:inf>m</ce:inf>), access conductance (<ce:italic>G</ce:italic><ce:inf>a</ce:inf>), membrane current and membrane potential were recorded unfiltered and then analyzed as in <ce:cross-ref refid="bib18">[18]</ce:cross-ref>. Values given as % Δ<ce:italic>C</ce:italic>/<ce:italic>C</ce:italic><ce:inf>slow</ce:inf> correspond to the % increases of the cell surface area.</ce:para></ce:section><ce:section><ce:label>2.3</ce:label><ce:section-title>FM styryl dye fluorescence</ce:section-title><ce:para>PC12-27 cell suspensions in KRH were transferred to fluorometer cuvettes and kept under continuous stirring. FM1-43 dye was added to 4<ce:hsp sp="0.25"/>μM (final concentration). After 5<ce:hsp sp="0.25"/>min, necessary to reach the dye equilibration, the cells were pretreated or not with the drugs and then exposed to ionomycin, and fluorescence intensity changes were recorded on-line (excitation and emission wavelengths: 479 and 598<ce:hsp sp="0.25"/>nm) using a LS50B fluorometer (Perkin–Elmer, Wellesley, MA, USA) <ce:cross-ref refid="bib19">[19]</ce:cross-ref>.</ce:para></ce:section><ce:section><ce:label>2.4</ce:label><ce:section-title>Statistics</ce:section-title><ce:para>Data were analyzed by the Student’s <ce:italic>t</ce:italic>-test.</ce:para></ce:section></ce:section><ce:section><ce:label>3</ce:label><ce:section-title>Results and discussion</ce:section-title><ce:para>Enlargeosomes are non-secretory organelles <ce:cross-refs refid="bib17 bib22">[17,22]</ce:cross-refs>. Their regulated exocytosis, therefore, can be investigated by monitoring not the discharge of a product, but the appearance to the cell surface of their luminal protein marker, d/A <ce:cross-refs refid="bib17 bib18 bib19 bib21">[17–19,21]</ce:cross-refs>. PC12-27 cells, untreated (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A, E) and pretreated for 5<ce:hsp sp="0.25"/>min with GNS (10, 30, 60 [not shown] and 100<ce:hsp sp="0.25"/>μM (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>B, E)) were almost d/A-negative. Three minutes treatment with 3<ce:hsp sp="0.25"/>μM ionomycin, a Ca<ce:sup>2+</ce:sup> ionophore, induced a considerable increase of the surface d/A labelling (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>C, E) which was much reinforced in the cells pretreated with GNS (<ce:cross-ref refid="fig1">Fig. 1</ce:cross-ref>D, E).</ce:para><ce:para>The difference between ionomycin and GNS<ce:hsp sp="0.25"/>+<ce:hsp sp="0.25"/>ionomycin-induced responses could be due to increased exocytosis, decreased endocytosis/shedding, or both. To distinguish between these possibilities we monitored by whole-cell patch-clamping the changes of capacitance, i.e. of cell surface area, taking place during caged Ca<ce:sup>2+</ce:sup> photolysis <ce:cross-ref refid="bib18">[18]</ce:cross-ref>, a process that induces [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> increases to μM levels without involvement of surface and intracellular channels <ce:cross-ref refid="bib18">[18]</ce:cross-ref>. <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref><ce:float-anchor refid="fig2"/>A–C shows that, in cells pretreated with 10<ce:hsp sp="0.25"/>μM GNS, the rise of capacitance induced by caged Ca<ce:sup>2+</ce:sup> photolysis was twice as fast and 2.5 larger than in non-pretreated cells. These results exclude a major contribution of enlargeosome endocytosis, which takes place in min <ce:cross-refs refid="bib18 bib19">[18,19]</ce:cross-refs>, and demonstrate the GNS-induced reinforcement of the Ca<ce:sup>2+</ce:sup>-induced exocytosis.</ce:para><ce:para>Increases of cell surface area can be assayed also by fluorometry, using styryl FM dyes <ce:cross-ref refid="bib19">[19]</ce:cross-ref>. <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>D, E shows FM1-43 results very similar to those obtained by patch-clamping, confirming, by using ionomycin, the large reinforcement of the [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf>-induced exocytosis in cells pretreated with GNS; <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>F, that the reinforcement occurred at GNS concentrations (10–300<ce:hsp sp="0.25"/>μM) known to inhibit TKs; <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>G, that the drug did not shift the dose-dependence of the ionomycin-induced cell surface enlargement rate but increased the efficacy of the ionophore; <ce:cross-ref refid="fig2">Fig. 2</ce:cross-ref>H, that the GNS reinforcement appeared after a few minutes and faded out after longer pre-treatments, suggesting a progressive desensitization.</ce:para><ce:para>Many drugs acting on either TKs or other GNS targets were employed to investigate the mechanism of the reinforcement. <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref><ce:float-anchor refid="tbl1"/> illustrates the action, low or absent, of various TK blockers and of drugs affecting additional, non-TK-dependent effects of GNS: lavendustinA, a large-spectrum blocker of TKs known to induce only few additional effects; the Src inhibitors, herbimycinA and PP2; piceatannol, a blocker of Syk and Lck; orthovanadate, an inhibitor of the tyrosine phosphatases, administered alone or together with GNS; daidzein, which induces most of the non-TK effects of GNS; UO126, a blocker of MEKs; LY294002, an inhibitor of PI<ce:inf>3</ce:inf> kinase; forskolin and IBMX, which increase [cAMP]<ce:inf>i</ce:inf> by stimulation of adenylate cyclase and inhibition of phosphodiesterase, respectively; H89, a blocker of protein kinase A. Also genistin, an inactive GNS analogue, failed to show any reinforcing effect.</ce:para><ce:para>The effect of GNS on the [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> response to ionomycin could not be checked directly because the florescence of the isoflavone interferes with that of [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> dyes. A role of [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> in the GNS reinforcement, however, appears highly unlikely because (1) in PC12-27 cells the exocytic response to 3<ce:hsp sp="0.25"/>μM ionomycin is poorly affected by agents, such as bradikynin, that induce [Ca<ce:sup>2+</ce:sup>]<ce:inf>i</ce:inf> rises by independent mechanisms; and (2) the GNS reinforcement was unchanged in cells preloaded with the cytosolic Ca<ce:sup>2+</ce:sup> chelator BAPTA (30<ce:hsp sp="0.25"/>min incubation with 30<ce:hsp sp="0.25"/>μM BAPTA-AM) (not shown). To investigate the involvement of the actin cytoskeleton we compared the reinforcement by GNS to that by latrunculinA, an actin depolymerizing drug also known as a stimulator of enlargeosome exocytosis <ce:cross-ref refid="bib21">[21]</ce:cross-ref>. The reinforcement by latrunculinA (5<ce:hsp sp="0.25"/>μM, 15<ce:hsp sp="0.25"/>min) was smaller than that by GNS (<ce:cross-ref refid="fig3">Fig. 3</ce:cross-ref><ce:float-anchor refid="fig3"/>). Interestingly, when the two drugs were combined, reinforcement was not additive. Overall, the results of <ce:cross-ref refid="tbl1">Table 1</ce:cross-ref> exclude the involvement of TK inhibition and of known additional effects of GNS. In contrast, an alteration of the cytoskeleton might contribute to the reinforcement of enlargeosome exocytosis.</ce:para><ce:para>Until recently, regulated exocytosis was identified with the final event of regulated secretion. Since 15 years, however, many non-secretory regulated exocytoses have been identified, necessary for important functions taking place either ubiquitously or in specialized cell types <ce:cross-ref refid="bib22">[22]</ce:cross-ref>. Enlargeosomes are widely expressed, non-secretory exocytic vesicles involved in the cell surface trafficking of membranes. Various properties of enlargeosomes and of their exocytosis: neutral pH of the lumen, membrane specificity, kinetics of discharge, recycling of the exocytized membrane <ce:cross-refs refid="bib19 bib20 bib21 bib22">[19–22]</ce:cross-refs>, are distinct from those of other exocytic organelles. The reinforcement by GNS of the Ca<ce:sup>2+</ce:sup>-induced exocytosis of enlargeosomes appears remarkable in size, analogous to effects of the drug observed previously only in neurons and pancreatic β cells. The latter effects, however, are induced by Src-specific blockers <ce:cross-refs refid="bib8 bib9">[8,9]</ce:cross-refs> that in our system were inactive. Our data revealed therefore a new property of enlargeosomes, distinct from those of the other exocytic organelles; and a new additional effect of GNS, independent on both the TK block and the non-TK effects of the drug known so far. Although poorly defined in mechanistic terms, our results may contribute to a comprehensive knowledge of the pharmacology of an important drug, widely employed in signal transduction studies.</ce:para></ce:section></ce:sections><ce:acknowledgment xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>Acknowledgements</ce:section-title><ce:para>We thank M. Rupnik, University of Maribor, for his hospitality in the patch clamp experiments. Supported by Grants from the CARIPLO Foundation (2006–0779) and the FIRB 2004 and PRIN 2006 Programs of the Italian Ministry of Research.</ce:para></ce:acknowledgment></body><tail><ce:bibliography xmlns:ce="http://www.elsevier.com/xml/common/dtd"><ce:section-title>References</ce:section-title><ce:bibliography-sec><ce:bib-reference id="bib1"><ce:label>[1]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Cox</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Ely</ce:surname></sb:author><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Catling</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Weber</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Parsons</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tyrosine kinases are required for catecholamine secretion and mitogen-activated protein kinase activation in bovine adrenal chromaffin cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurochem.</sb:maintitle></sb:title><sb:volume-nr>66</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1103</sb:first-page><sb:last-page>1112</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>[2]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>M.P.</ce:given-name><ce:surname>Lutz</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Piiper</ce:surname></sb:author><sb:author><ce:given-name>H.Y.</ce:given-name><ce:surname>Gaisano</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Stryjek-Kaminska</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Zeuzem</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Adler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Protein tyrosine phosphorylation in pancreatic acini: differential effects of VIP and CCK</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>273</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>G1226</sb:first-page><sb:last-page>G1232</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>[3]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Mocsai</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Jakus</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Vantus</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Berton</ce:surname></sb:author><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>Lowell</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Ligeti</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Immunol.</sb:maintitle></sb:title><sb:volume-nr>164</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>4321</sb:first-page><sb:last-page>4331</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>[4]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.N.</ce:given-name><ce:surname>Tomes</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Roggero</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>De Blas</ce:surname></sb:author><sb:author><ce:given-name>P.M.</ce:given-name><ce:surname>Saling</ce:surname></sb:author><sb:author><ce:given-name>L.S.</ce:given-name><ce:surname>Mayorga</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Requirement of protein tyrosine kinase and phosphatase activities for human sperm exocytosis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>265</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>399</sb:first-page><sb:last-page>415</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>[5]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.P.</ce:given-name><ce:surname>Wheeler-Jones</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>May</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Morgan</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Pearson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. J.</sb:maintitle></sb:title><sb:volume-nr>315</sb:volume-nr></sb:series><sb:issue-nr>Pt 2</sb:issue-nr><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>407</sb:first-page><sb:last-page>416</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>[6]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>L.H.</ce:given-name><ce:surname>Abdullah</ce:surname></sb:author><sb:author><ce:given-name>C.W.</ce:given-name><ce:surname>Davis</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulation of airway goblet cell mucin secretion by tyrosine phosphorylation signaling pathways</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Lung Cell Mol. Physiol.</sb:maintitle></sb:title><sb:volume-nr>293</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>L591</sb:first-page><sb:last-page>L599</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>[7]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>C.H.</ce:given-name><ce:surname>Cho</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Song</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Leitzell</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Teo</ce:surname></sb:author><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Meleth</ce:surname></sb:author><sb:author><ce:given-name>M.W.</ce:given-name><ce:surname>Quick</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Lester</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Rapid upregulation of alpha7 nicotinic acetylcholine receptors by tyrosine dephosphorylation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>3712</sb:first-page><sb:last-page>3723</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>[8]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Cheng</ce:surname></sb:author><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Straub</ce:surname></sb:author><sb:author><ce:given-name>G.W.</ce:given-name><ce:surname>Sharp</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Inhibitory role of Src family tyrosine kinases on Ca<ce:sup>2+</ce:sup>-dependent insulin release</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Endocrinol. Metab.</sb:maintitle></sb:title><sb:volume-nr>292</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>E845</sb:first-page><sb:last-page>E852</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>[9]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ohnishi</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamamori</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Ono</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Aoyagi</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kondo</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A src family tyrosine kinase inhibits neurotransmitter release from neuronal cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>10930</sb:first-page><sb:last-page>10935</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>[10]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.G.</ce:given-name><ce:surname>Shyu</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Jow</ce:surname></sb:author><sb:author><ce:given-name>Y.J.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Wang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>PP2 inhibits glutamate release from nerve endings by affecting vesicle mobilization</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuroreport</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1969</sb:first-page><sb:last-page>1972</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>[11]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.B.</ce:given-name><ce:surname>Pereira</ce:surname></sb:author><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Carvalho</ce:surname></sb:author><sb:author><ce:given-name>C.B.</ce:given-name><ce:surname>Duarte</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Genistein inhibits Ca<ce:sup>2+</ce:sup> influx and glutamate release from hippocampal synaptosomes: putative non-specific effects</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurochem. Int.</sb:maintitle></sb:title><sb:volume-nr>42</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>179</sb:first-page><sb:last-page>188</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>[12]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.E.</ce:given-name><ce:surname>Belevych</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Warrier</ce:surname></sb:author><sb:author><ce:given-name>R.D.</ce:given-name><ce:surname>Harvey</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Genistein inhibits cardiac L-type Ca(<ce:sup>2+</ce:sup>) channel activity by a tyrosine kinase-independent mechanism</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Pharmacol.</sb:maintitle></sb:title><sb:volume-nr>62</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>554</sb:first-page><sb:last-page>565</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>[13]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>K.M.</ce:given-name><ce:surname>Burvall</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Palmberg</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Larsson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The tyrosine kinase inhibitor genistein increases basal cAMP and potentiates forskolin-induced cAMP accumulation in A549 human airway epithelial cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell Biochem.</sb:maintitle></sb:title><sb:volume-nr>240</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>131</sb:first-page><sb:last-page>133</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>[14]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Zhen</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Carter</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Si</ce:surname></sb:author><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Reynolds</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Diabetes</sb:maintitle></sb:title><sb:volume-nr>55</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1043</sb:first-page><sb:last-page>1050</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>[15]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gong</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Nederlijkovic-Kurepa</ce:surname></sb:author><sb:author><ce:given-name>F.H.</ce:given-name><ce:surname>Sarkar</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>4702</sb:first-page><sb:last-page>4709</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>[16]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Goldberg</ce:surname></sb:author><sb:author><ce:given-name>D.Y.</ce:given-name><ce:surname>Wu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Inhibition of formation of filopodia after axotomy by inhibitors of protein tyrosine kinases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurobiol.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>553</sb:first-page><sb:last-page>560</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>[17]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Borgonovo</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Cocucci</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Racchetti</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Podini</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Bachi</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulated exocytosis: a novel, widely expressed system</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>955</sb:first-page><sb:last-page>962</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>[18]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Cocucci</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Racchetti</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Podini</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Rupnik</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Enlargeosome, an exocytic vesicle resistant to nonionic detergents, undergoes endocytosis via a nonacidic route</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Biol. Cell</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>5356</sb:first-page><sb:last-page>5368</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>[19]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Cocucci</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Racchetti</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Podini</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Enlargeosome traffic: exocytosis triggered by various signals is followed by endocytosis, membrane shedding or both</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Traffic</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>742</sb:first-page><sb:last-page>757</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>[20]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kasai</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kishimoto</ce:surname></sb:author><sb:author><ce:given-name>T.T.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Miyashita</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Podini</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Grohovaz</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiple and diverse forms of regulated exocytosis in wild-type and defective PC12 cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>945</sb:first-page><sb:last-page>949</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>[21]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Lorusso</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Covino</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Priori</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Bachi</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Chieregatti</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Annexin2 coating the surface of enlargeosomes is needed for their regulated exocytosis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>5443</sb:first-page><sb:last-page>5456</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>[22]</ce:label><sb:reference xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd"><sb:contribution><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Chieregatti</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Meldolesi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Regulated exocytosis: new organelles for non-secretory purposes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Rev. Mol. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>181</sb:first-page><sb:last-page>187</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article>
